GHK-Cu and Hair Growth: What Has Been Studied
What the research covers
A PubMed search found no trial of GHK-Cu on its own for hair growth. Human hair data come from products that joined GHK, or mixed copper peptides, with other agents.
GHK-Cu is a small peptide, glycyl-histidyl-lysine, bound to copper. In a 2016 trial, 45 men with pattern hair loss sprayed their scalp once a day for 6 months. The full paper lists 43 men randomised to the three groups. Two groups got a spray called ALAVAX, and one group got a placebo. ALAVAX joins GHK to 5-aminolevulinic acid and has no copper. Hair counts rose by 52.6 and 71.5 in the two ALAVAX groups and by 9.6 with placebo. Hair length and thickness did not differ. No side effects were reported in any group.
A 2025 report looked back at 7 men who had five monthly scalp tattooing sessions. Each session put minoxidil, dutasteride and 1.2 percent copper peptides into the scalp. Scalp coverage scores improved, but there was no placebo group. The effect of the copper peptides alone cannot be separated from the other drugs. In a 2007 lab study, a different copper peptide, AHK-Cu, lengthened human hair follicles. That study did not test GHK-Cu.
Sources
- Lee WJ, Sim HB, Jang YH, et al. Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth Ann Dermatol (2016). PMID 27489425 doi:10.5021/ad.2016.28.4.438 Placebo-controlled trial, 45 men with pattern hair loss; scalp spray of GHK joined to 5-ALA (no copper), once daily for 6 months.
- Kuceki G, Coppinger AJ, Ragi SD, et al. Enhanced hair regrowth with five monthly sessions of minoxidil-dutasteride-copper peptides tattooing for androgenetic alopecia assessed by artificial intelligence and blinded evaluators JAAD Int (2025). PMID 40225275 doi:10.1016/j.jdin.2025.01.012 Look-back report, 7 men; five monthly scalp tattooing sessions with minoxidil, dutasteride and 1.2% copper peptides; no placebo group.
- Miller TR, Wagner JD, Baack BR, et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin Arch Facial Plast Surg (2006). PMID 16847171 doi:10.1001/archfaci.8.4.252 Defines GHK-Cu as glycyl-l-histidyl-l-lysine-Cu(2+); cited here for the definition only.
- Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro Arch Pharm Res (2007). PMID 17703734 doi:10.1007/BF02978833 Lab study of AHK-Cu, a different copper tripeptide, on human hair follicles and dermal papilla cells.
Frequently Asked Questions
Has GHK-Cu alone been tested for hair growth in humans?
What did the 2016 GHK hair trial find?
What is the evidence for copper peptides with minoxidil?
Is there lab evidence on copper peptides and hair follicles?
More GHK-Cu research
Deep dives on GHK-Cu
- Best Peptides for Injury Recovery: What the Evidence ShowsBest peptides for injury recovery, weighed on the evidence: what BPC-157, TB-500, GHK-Cu and four others were studied in, plus FDA's legal record in 2026.
- BPC-157 and TB-500: What the Wolverine Stack Research ShowsBPC-157 and TB-500 (Wolverine stack): no study tested the pair. See the doses the FDA reports from human studies, what was tried together and the safety record.
- How to Reconstitute Peptides: Diluents, Maths and StorageHow to reconstitute peptides, from primary sources: the diluents an FDA label names, the concentration maths, what damages a peptide, and storage figures.
- BPC-157 vs TB-500 Comparison: What the Research ShowsBPC-157 vs TB-500 comparison: what each healing peptide does, what the rat, lab-dish and eye studies found, and why neither has a human injury trial yet.
This content is for educational purposes only. These compounds are intended for research use. Nothing here is medical advice.
Get the weekly UB newsletter
One email every Friday: new protocols, research breakdowns, and tactical guides. No spam. Unsubscribe anytime.
